New News information at Pharmaceutical Technology New and updated information from News listed on www.pharmaceutical-technology.com http://www.pharmaceutical-technology.com/ en-us http://www.pharmaceutical-technology.com/ New News information at Pharmaceutical Technology http://www.pharmaceutical-technology.com/content/images/logo_big.gif Deals this week: Ribomic, Puridify, Ferring Pharmaceuticals http://www.pharmaceutical-technology.com/news/newsdeals-this-week-ribomic-inc-puridify-limited-ferring-pharmaceuticals-5691270 http://www.pharmaceutical-technology.com/news/newsdeals-this-week-ribomic-inc-puridify-limited-ferring-pharmaceuticals-5691270 Biopharmaceutical company Ribomic and biotechnology company Evec have both entered a research agreement. Fri, 09 Dec 2016 00:00:00 GMT M&As this week: Teledyne Technologies Incorporated, AddLife http://www.pharmaceutical-technology.com/news/newsmas-this-week-teledyne-technologies-incorporated-addlife-ab-5691288 http://www.pharmaceutical-technology.com/news/newsmas-this-week-teledyne-technologies-incorporated-addlife-ab-5691288 Teledyne Technologies Incorporated has acquired Hanson Research Corporation. Fri, 09 Dec 2016 00:00:00 GMT Study finds chemotherapy drug combination may cause women to grow new eggs http://www.pharmaceutical-technology.com/news/newschemotherapy-drug-combination-may-cause-women-to-grow-new-eggs-finds-study-5691663 http://www.pharmaceutical-technology.com/news/newschemotherapy-drug-combination-may-cause-women-to-grow-new-eggs-finds-study-5691663 Women treated with a common chemotherapy drug combination may cause them to subsequently grow more young eggs in their ovaries, according to a study conducted by University of Edinburgh. Thu, 08 Dec 2016 00:00:00 GMT SRI wins $150m contract to accelerate production of HIV-prevention products http://www.pharmaceutical-technology.com/news/newssri-wins-150m-contract-to-accelerate-production-of-hiv-prevention-products-5691477 http://www.pharmaceutical-technology.com/news/newssri-wins-150m-contract-to-accelerate-production-of-hiv-prevention-products-5691477 US-based SRI International has been contracted by the National Institutes of Health’s National Institute of Allergy and Infectious Diseases and the Division of AIDS (NIAID-DAIDS) to provide development and manufacturing support for HIV microbicides a… Thu, 08 Dec 2016 00:00:00 GMT Bristol-Myers Squibb's Opdivo approved to treat blood cancer in EU http://www.pharmaceutical-technology.com/news/newsbristol-myers-squibbs-opdivo-approved-to-treat-blood-cancer-in-eu-5689641 http://www.pharmaceutical-technology.com/news/newsbristol-myers-squibbs-opdivo-approved-to-treat-blood-cancer-in-eu-5689641 Bristol-Myers Squibb's drug Opdivo (nivolumab) has been approved for use in the European Union (EU) to treat classical Hodgkin lymphoma (cHL), a type of blood cancer. Thu, 08 Dec 2016 00:00:00 GMT AbbVie partners with Johns Hopkins University for cancer research http://www.pharmaceutical-technology.com/news/newsabbvie-partners-with-johns-hopkins-university-for-cancer-research-5689632 http://www.pharmaceutical-technology.com/news/newsabbvie-partners-with-johns-hopkins-university-for-cancer-research-5689632 Biopharmaceutical firm AbbVie has signed a five-year collaboration agreement with the Johns Hopkins University School of Medicine to advance medical oncology research and discovery. Wed, 07 Dec 2016 00:00:00 GMT BTG launches DC Bead LUMI for liver cancer patients in Canada http://www.pharmaceutical-technology.com/news/newsbtg-launches-dc-bead-lumi-for-liver-cancer-patients-in-canada-5688409 http://www.pharmaceutical-technology.com/news/newsbtg-launches-dc-bead-lumi-for-liver-cancer-patients-in-canada-5688409 BTG International has launched a next-generation treatment option, DC Bead LUMI, for cancer patients in Canada, marking its first worldwide market commercialisation. Wed, 07 Dec 2016 00:00:00 GMT UK's CMA fines Pfizer and Flynn Pharma nearly £90m for unfair pricing of epilepsy drug http://www.pharmaceutical-technology.com/news/newsuks-cma-fines-pfizer-flynn-pharma-nearly-90m-for-unfair-pricing-of-epilepsy-drug-5690357 http://www.pharmaceutical-technology.com/news/newsuks-cma-fines-pfizer-flynn-pharma-nearly-90m-for-unfair-pricing-of-epilepsy-drug-5690357 Pfizer and Flynn Pharma have been fined nearly £90m by the Competition and Markets Authority (CMA) for charging unfair prices in the UK for phenytoin sodium capsules, an anti-epilepsy drug. Wed, 07 Dec 2016 00:00:00 GMT Melbourne scientists develop first therapeutic dental vaccine http://www.pharmaceutical-technology.com/news/newsmelbourne-scientists-develop-first-therapeutic-dental-vaccine-5688342 http://www.pharmaceutical-technology.com/news/newsmelbourne-scientists-develop-first-therapeutic-dental-vaccine-5688342 Scientists at the University of Melbourne have developed a therapeutic dental vaccine to avoid or minimise treatment using surgery and antibiotics for severe gum disease. Tue, 06 Dec 2016 00:00:00 GMT New Myeloma Genome Project established to advance diagnosis and treatments http://www.pharmaceutical-technology.com/news/newsnew-myeloma-genome-project-established-to-advance-diagnosis-and-treatments-5687673 http://www.pharmaceutical-technology.com/news/newsnew-myeloma-genome-project-established-to-advance-diagnosis-and-treatments-5687673 Celgene, the Dana-Farber Cancer Institute and the University of Arkansas for Medical Sciences have collaboratively launched a new initiative known as the Myeloma Genome Project. Tue, 06 Dec 2016 00:00:00 GMT Novimmune and Genentech enter exclusive licence agreement for rheumatoid arthritis drug http://www.pharmaceutical-technology.com/news/newsnovimmune-genentech-enter-exclusive-licence-agreement-for-rheumatoid-arthritis-drug-5688327 http://www.pharmaceutical-technology.com/news/newsnovimmune-genentech-enter-exclusive-licence-agreement-for-rheumatoid-arthritis-drug-5688327 Swiss Biotech firm Novimmune has entered into an option and licence agreement with Roche company Genentech to develop and commercialise its anti-toll-like receptor 4 (TLR4) monoclonal antibody, NI-0101, to treat rheumatoid arthritis and other auto-im… Tue, 06 Dec 2016 00:00:00 GMT GSK finalises agreement with Brazilian MoH for Tivicay supply http://www.pharmaceutical-technology.com/news/newsgsk-finalises-agreement-with-brazilian-moh-for-tivicay-supply-5687315 http://www.pharmaceutical-technology.com/news/newsgsk-finalises-agreement-with-brazilian-moh-for-tivicay-supply-5687315 GSK has finalised an agreement with the Brazilian Ministry of Health (MoH) for the supply of Tivicay (dolutegravir). Mon, 05 Dec 2016 00:00:00 GMT UK scientists create map of licensed drugs to search for future treatments http://www.pharmaceutical-technology.com/news/newsuk-scientists-create-map-of-licensed-drugs-to-search-for-future-treatments-5687333 http://www.pharmaceutical-technology.com/news/newsuk-scientists-create-map-of-licensed-drugs-to-search-for-future-treatments-5687333 UK-based scientists at the Institute of Cancer Research (ICR) have created a map of all 1,578 licensed drugs and their mechanisms of action to identify ‘uncharted waters’ in the search for future treatments. Mon, 05 Dec 2016 00:00:00 GMT EIB to support Amryt Pharma’s new treatment for skin disorders http://www.pharmaceutical-technology.com/news/newseib-to-support-amryt-pharmas-new-treatment-for-skin-disorders-5687329 http://www.pharmaceutical-technology.com/news/newseib-to-support-amryt-pharmas-new-treatment-for-skin-disorders-5687329 The European Investment Bank (EIB) will grant a €20m loan to support a new treatment being developed by Irish company Amryt Pharma for skin disorders. Mon, 05 Dec 2016 00:00:00 GMT Cancer Research UK to invest £226m in cancer research http://www.pharmaceutical-technology.com/news/newscancer-research-uk-to-invest-226m-in-cancer-research-5686114 http://www.pharmaceutical-technology.com/news/newscancer-research-uk-to-invest-226m-in-cancer-research-5686114 Cancer Research UK has announced an investment of £190m in 13 centres over the next five years. Fri, 02 Dec 2016 00:00:00 GMT M&As this week: Thermo Fisher Scientific, Heptares Therapeutics http://www.pharmaceutical-technology.com/news/newsmas-this-week-thermo-fisher-scientific-heptares-therapeutics-5684978 http://www.pharmaceutical-technology.com/news/newsmas-this-week-thermo-fisher-scientific-heptares-therapeutics-5684978 Thermo Fisher Scientific has announced its decision to acquire MTI-GlobalStem. Pursuant to the acquisition, MTI-GlobalStem will be merged into Thermo Fisher’s life sciences solution segment. Fri, 02 Dec 2016 00:00:00 GMT NICE recommends GSK's new injectable asthma drug Nucala http://www.pharmaceutical-technology.com/news/newsnice-recommends-gsks-new-injectable-asthma-drug-nucala-5686140 http://www.pharmaceutical-technology.com/news/newsnice-recommends-gsks-new-injectable-asthma-drug-nucala-5686140 UK’s National Institute for Health and Care Excellence (NICE) has recommended GlaxoSmithKline's (GSK) new injectable asthma drug Nucala (Mepolizumab) for use in the country’s state-run health service in the most severe patients. Fri, 02 Dec 2016 00:00:00 GMT Deals this week: Genetic Analysis, Boehringer Ingelheim, Vigene Biosciences http://www.pharmaceutical-technology.com/news/newsdeals-this-week-genetic-analysis-boehringer-ingelheim-gmbh-vigene-biosciences-inc-5684963 http://www.pharmaceutical-technology.com/news/newsdeals-this-week-genetic-analysis-boehringer-ingelheim-gmbh-vigene-biosciences-inc-5684963 Genetic Analysis and Bio-Rad Laboratories have entered an agreement to further develop GA-map technology in routine healthcare. Fri, 02 Dec 2016 00:00:00 GMT Rwanda becomes third country to launch Novartis Access programme http://www.pharmaceutical-technology.com/news/newsrwanda-becomes-third-country-to-launch-novartis-access-programme-5684845 http://www.pharmaceutical-technology.com/news/newsrwanda-becomes-third-country-to-launch-novartis-access-programme-5684845 Novartis has announced that Rwanda signed a memorandum of understanding (MoU) and became the third country after Kenya and Ethiopia to launch the Novartis Access programme. Thu, 01 Dec 2016 00:00:00 GMT Takeda to invest more than €100m in manufacturing plant for dengue vaccine in Germany http://www.pharmaceutical-technology.com/news/newstakeda-to-invest-100m-in-manufacturing-plant-for-dengue-vaccine-in-germany-5684828 http://www.pharmaceutical-technology.com/news/newstakeda-to-invest-100m-in-manufacturing-plant-for-dengue-vaccine-in-germany-5684828 Takeda Pharmaceuticals has announced plans to invest more than €100m to build a new manufacturing plant for its dengue vaccine candidate in Singen, Germany. Thu, 01 Dec 2016 00:00:00 GMT